ArticleObesity surgery2026
The Weight of a New Heart: Bariatric Surgery after Heart Transplantation and its Clinical Impact.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionSevere obesity (SO) after heart transplantation (HT) worsens long-term graft and patient outcomes. While bariatric surgery (BS) is effective for obesity, its safety and efficacy in heart transplant recipients (HTR) remains poorly defined.
methodsUsing the TrinetX® database, we conducted a retrospective cohort study of adult HTR with BMI ≥ 35 kg/m² between 2000 and 2023. Patients were divided into HTR with post-transplant BS (HTR/BS) and HTR without BS. Propensity score matching adjusted for age, sex, race, ethnicity, and BMI. Primary outcomes were 30-day post-BS complications. Secondary outcomes included mortality, heart failure, coronary artery disease, transplant complications and malignancy up to 5 years following BS.
resultsIn total, 375 patients (HTR/BS − 27; HTR − 348) were analyzed. HTR/BS had no 30-day mortality or major surgical complications. Heart failure rates were significantly lower in HTR/BS cohort at 1 and 3 years, but not at 5 years (13 vs. 24, OR 0.12, p = 0.003; 14 vs. 24, OR 0.14, p = 0.007; 18 vs. 24, OR 0.26, p = 0.1, respectively). At 5 years, transplant complications were significantly lower in HTR/BS vs. HTR (33% vs. 94%, OR 0.1, p = 0.001). Trends toward lower coronary disease were observed in HTR/BS but did not reach significance.
conclusionBariatric surgery is safe in selected HTR and may reduce long-term transplant complications. These findings support BS as a viable intervention for management of obesity post-HT, warranting further prospective validation.
Indexed as
Identifiers
41588204What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.